Varianteninterpretation in der molekularen Pathologie und Onkologie-Reference-Cited by-同舟云学术

Varianteninterpretation in der molekularen Pathologie und Onkologie

Published:2021-05-03 Issue:4 Volume:42 Page:369-379
ISSN:0172-8113
Container-title:Der Pathologe
language:de
Short-container-title:Pathologe

Author:

Horak Peter,Leichsenring Jonas,Kreutzfeldt Simon,Kazdal Daniel,Teleanu Veronica,Endris Volker,Volckmar Anna-Lena,Renner Marcus,Kirchner Martina,Heilig Christoph E.,Neumann Olaf,Schirmacher Peter,Fröhling Stefan,Stenzinger Albrecht

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00292-021-00938-5.pdf

Reference41 articles.

1. Bijlsma R, Wouters R, Wessels H et al (2020) Preferences to receive unsolicited findings of germline genome sequencing in a large population of patients with cancer. ESMO Open. https://doi.org/10.1136/esmoopen-2019-000619

2. Califf RM (2018) Biomarker definitions and their applications. Exp Biol Med (Maywood) 243:213–221

3. Cherny NI, Dafni U, Bogaerts J et al (2017) ESMO-magnitude of clinical benefit scale version 1.1. Ann Oncol 28:2340–2366

4. De Vries EGE, Cherny NI, Voest EE (2019) When is off-label off-road? Ann Oncol 30:1536–1538

5. Dickson D, Johnson J, Bergan R et al (2020) The master observational trial: a new class of master protocol to advance precision medicine. Cell 180:9–14

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determinants Affecting the Clinical Implementation of a Molecularly Informed Molecular Tumor Board Recommendation: Experience from a Tertiary Cancer Center;Cancers;2023-12-18

2. Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study;JMIR Medical Informatics;2023-12-11

3. Extending cBioPortal for Therapy Recommendation Documentation in Molecular Tumor Boards: Development and Usability Study (Preprint);2023-06-16

4. S1-Leitlinie: Tumorgenetik – Diagnostik im Kontext maligner Erkrankungen;Medizinische Genetik;2022-04-01

5. Erratum zu: Varianteninterpretation in dermolekularen Pathologie und Onkologie;Der Pathologe;2021-10-04